GLP-1 Advisor | One Day MD

Part of the GLP-1 Resource Hub | By Dr. Francis Yap | Verified as of November 2026 Quick Answer No single platform wins every category. In U.S. News’s first-ever GLP-1 telehealth ratings (August 12, 2026), Amazon One Medical scored highest (4.8) and led on insurance support, Found led on clinical support, Noom on supplemental support and Ro on customer satisfaction. If you already have a prescription and no coverage, manufacturer cash-pay programs (LillyDirect, NovoCare, via TrumpRx) are the lowest-cost branded route. Eligible Medicare enrollees can pay $50 a month through the temporary GLP-1 Bridge. Treat compounded products with caution. In this guide How U.S. News rated the platforms Best by category Pricing snapshot Medicare and insurance Compounded GLP-1s Evidence...

Home › GLP-1 Hub By Dr. Frank Yap, MD  |  Last updated: November 2026  |  Purpose: evidence and safety education, not individual medical advice Quick Answer GLP-1 therapy now includes injections and, since 2025–2026, two FDA-approved pills : oral Wegovy (semaglutide 25 mg, December 2025) and Foundayo (orforglipron) , approved April 1, 2026 as the first non-peptide oral GLP-1 for weight management.  The 5 November 2026 Science special issue (“GLP-1 and Beyond”) examines how GLP-1 receptor agonists and related metabolism-targeting drugs affect systems beyond classic metabolic disease—especially the brain—while highlighting the shift toward multi-receptor agents. Retatrutide is not approved anywhere ; it remains in Phase 3 testing. Compounded and gray-market GLP-1 or peptide products are not FDA-approved, and the FDA issued warning letters to telehealth compounders in March 2026. Any GLP-1 plan should run through a licensed physician and a regu...